c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.

Tsakonas, Georgios

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 07 2019 - 69-74 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1872-8332

10.1016/j.lungcan.2019.04.028 doi


Aged
Biomarkers, Tumor--metabolism
Carcinoma, Non-Small-Cell Lung--diagnosis
Chemotherapy, Adjuvant--methods
Cohort Studies
Female
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Lung Neoplasms--diagnosis
Male
Middle Aged
Neoplasm Staging
Prognosis
Proto-Oncogene Proteins c-met--metabolism
Retrospective Studies
Survival Analysis